Related Experiment Videos
DNA polymorphism of the C4 genes. A new marker for analysis of the major histocompatibility complex
Insights
Researchers identified new DNA-level variations in the human complement C4 gene within the major histocompatibility complex (MHC). These C4 gene polymorphisms offer enhanced genetic markers for transplantation and MHC-linked diseases like congenital adrenal hyperplasia.
Area of Science:
- Immunogenetics
- Human Molecular Genetics
Background:
- Major histocompatibility complex (MHC) polymorphisms are crucial for organ transplantation and understanding MHC-linked diseases.
- Existing MHC markers have limitations in scope and resolution.
Purpose of the Study:
- To identify novel polymorphic markers within the MHC region.
- To characterize DNA-level variants of the fourth component of human complement (C4).
Main Methods:
- Utilized a complementary DNA (cDNA) probe specific for human C4.
- Analyzed DNA polymorphisms at the C4 locus within the MHC.
- Examined inheritance patterns of identified polymorphisms.
Main Results:
- Discovered new polymorphic variants at the DNA level for C4 within the MHC.
- These C4 genomic polymorphisms are inherited with the HLA-DR and complement loci on chromosome 6.
- Identified DNA variants in individuals with identical C4 protein phenotypes.
Conclusions:
- C4 genomic polymorphisms represent a new, valuable genetic marker within the MHC.
- This marker exhibits autosomal codominant inheritance.
- Demonstrated utility of C4 polymorphisms in evaluating 21-hydroxylase-deficiency congenital adrenal hyperplasia and other MHC-linked conditions.
Abstract:
Polymorphisms of the proteins encoded by genes that lie within the major histocompatibility complex (MHC) have served as useful markers for organ transplantation and in genetic analysis of a large number of MHC-linked diseases. To extend the range of MHC polymorphic markers, we used a complementary-DNA probe specific for the fourth component of human complement (C4) to identify a new variant within the MHC. Polymorphic variants at the DNA level were detected among subjects with identical phenotypes of the corresponding protein. C4 genomic polymorphisms are inherited with the segment of the short arm of chromosome 6 that carries the HLA-DR and complement loci. The autosomal codominant mode of inheritance of this genetic marker and its utility for evaluation of 21-hydroxylase-deficiency congenital adrenal hyperplasia, one of the many MHC-linked diseases, were established.